Mizuho Maintains Neutral on Abbott Laboratories, Raises Price Target to $130
Portfolio Pulse from Benzinga Newsdesk
Mizuho analyst Anthony Petrone maintains a Neutral rating on Abbott Laboratories (NYSE:ABT) and raises the price target from $115 to $130.
October 17, 2024 | 1:16 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Mizuho analyst Anthony Petrone maintains a Neutral rating on Abbott Laboratories but raises the price target from $115 to $130, indicating a positive outlook on the stock's potential.
The increase in the price target from $115 to $130 suggests a positive outlook on Abbott Laboratories' future performance. Although the rating remains Neutral, the raised target indicates potential for stock appreciation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100